Meet the dedicated teams at St. Dominic's who make our theranostic program possible, offering cutting-edge treatments like Lutathera and Pluvicto to our patients – St. Dominic’s Outpatient Infusion and Nuclear Medicine.
Lutathera is a targeted therapy used to treat neuroendocrine tumors, slowing their growth or, in some cases, halting it altogether, based on the latest research. Pluvicto, on the other hand, is a breakthrough treatment for metastatic prostate cancer, offering new hope for patients with advanced stages of the disease. Both therapies also help manage symptoms associated with these conditions.
Because these treatments require specialized facilities and expertise, access can be limited. We're proud that our collaborative teams at St. Dominic’s are expanding access to these life-changing therapies, bringing hope to those we serve.
Learn more about St. Dominic Comprehensive Cancer Program at
bit.ly/417wywM.
See research on Lutathera:
bit.ly/4hZjKPW.
See research on Pluvicto:
bit.ly/417uCUQ